Microbe Engineered to Thrive in Toxic Methanol for Bioplastic Production

Overcoming the Methanol Toxicity Barrier

In a significant breakthrough for the biomanufacturing sector, a South Korean research team has announced the development of a highly resilient microbial strain engineered to thrive in toxic methanol environments. This development addresses one of the most persistent challenges in industrial biotechnology: utilizing cheap, abundant C1 gases like methanol as a feedstock without killing the production organisms.

Methanol, which can be derived from industrial waste gases or captured carbon dioxide, has long been viewed as an ideal, non-food feedstock for bioplastics. However, its high toxicity to most microorganisms has severely limited its commercial viability. High concentrations typically disrupt cellular membranes and halt metabolic functions, making efficient bioconversion impossible.

Synthetic Biology Drives Efficiency

Using advanced synthetic biology and adaptive evolution techniques, the research team successfully modified the metabolic pathways of the target bacteria. The engineered strain not only survives in high-methanol environments but effectively metabolizes the chemical, converting it into intracellular biopolymers, specifically polyhydroxyalkanoates (PHA).

The new strain demonstrates a robust tolerance level significantly higher than wild-type counterparts, maintaining high cell density and productivity even when methanol is used as the sole carbon source. This efficiency is crucial for lowering the production costs of PHA, which has historically struggled to compete with fossil-fuel-based plastics due to expensive sugar-based feedstocks.

Implications for Industrial Scale-up

This development opens the door for a new generation of “gas-to-plastic” technologies. By decoupling bioplastic production from agricultural land use (sugar and corn) and instead utilizing industrial byproducts, manufacturers can achieve a lower carbon footprint and reduced raw material costs.

The research team is now focusing on optimizing the fermentation process for pilot-scale testing, aiming to transfer the technology to industrial partners for mass production.

Source: Read more